title: Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar.
authors.forename: Bart L
authors.initials: BL
authors.lastname: De Keulenaer
authors.forename: Dianne P
authors.initials: DP
authors.lastname: Stephens
mesh_terms: D000818:Animals; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D007022:Hypotension / Q000188:drug therapy*; D007511:Ischemia / Q000139:chemically induced*; D008236:Lypressin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats; D012772:Shock, Septic / Q000188:drug therapy*; D013152:Splanchnic Circulation / Q000187:drug effects*; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin